![Michael Burgess](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Burgess
Director/Miembro de la Junta en
iOmx Therapeutics AG
.
Perfil
Michael M.
Burgess currently works at The Royal College of Physicians, as Member, The Royal College of Paediatrics & Child Health, as Member, and iOmx Therapeutics AG, as Member-Supervisory Board from 2022.
Dr. Burgess also formerly worked at Turnstone Biologics Corp., as Director from 2024 to 2025, Synlogic, Inc., as Independent Director from 2020 to 2024, Bristol Myers Squibb Co., as SVP-Discovery Medicine & Clinical Pharmacology, Roche Holding AG, as Head-Oncology Discovery & Translational Area in 2012, Hoffmann-La Roche, Inc., as Global Head-DTA Oncology Division, Roche Holding (UK) Ltd., as Head-Clinical Research Division in 2010, Roche Ltd., as Head-Oncology Discovery & Translational Area, and Springworks Therapeutics, Inc., as Head-Research & Development from 2021 to 2022.
Dr. Burgess received his graduate degree in 1989 from the University of Bristol and doctorate degree in 1999 from the University of Bristol.
Cargos activos de Michael Burgess
| Empresas | Cargo | Inicio |
|---|---|---|
The Royal College of Physicians
 The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
The Royal College of Paediatrics & Child Health
 The Royal College of Paediatrics & Child Health Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
iOmx Therapeutics AG
 iOmx Therapeutics AG BiotechnologyHealth Technology Develops immunotherapy treatments for cancer patients | Director/Miembro de la Junta | 20/07/2022 |
Antiguos cargos conocidos de Michael Burgess.
| Empresas | Cargo | Fin |
|---|---|---|
| TURNSTONE BIOLOGICS CORP. | Director Técnico/Científico/I+D | 01/11/2024 |
| SYNLOGIC, INC. | Director/Miembro de la Junta | 20/03/2024 |
| SPRINGWORKS THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 16/09/2022 |
Roche Holding (UK) Ltd.
 Roche Holding (UK) Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and sells drugs | Corporate Officer/Principal | 01/01/2010 |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Corporate Officer/Principal | - |
Formación de Michael Burgess.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
90
Relaciones de 1er grado
12
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 12 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Roche Holding AG
 Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Health Technology |
University of Bristol
 University of Bristol Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roche Holding (UK) Ltd.
Roche Holding (UK) Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and sells drugs | Health Technology |
The Royal College of Physicians
The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roche Ltd.
 Roche Ltd. Financial ConglomeratesFinance Provides investment services | Finance |
The Royal College of Paediatrics & Child Health
The Royal College of Paediatrics & Child Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
iOmx Therapeutics AG
iOmx Therapeutics AG BiotechnologyHealth Technology Develops immunotherapy treatments for cancer patients | Health Technology |
Synlogic, Inc.
 Synlogic, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Turnstone Biologics Corp.
 Turnstone Biologics Corp. BiotechnologyHealth Technology Develops and sells medicines to treat and cure solid tumors | Health Technology |
Springworks Therapeutics, Inc.
 Springworks Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes medicines for nervous system disorders | Health Technology |
- Bolsa de valores
- Insiders
- Michael Burgess
